이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Choksi Laboratories 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sunil Choksi

최고 경영자

₹4.2m

총 보상

CEO 급여 비율	n/a
CEO 임기	15.8yrs
CEO 소유권	13.3%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	10.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Sunil Choksi 의 보수는 Choksi Laboratories 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	₹11m
Dec 31 2023	n/a	n/a	₹34m
Sep 30 2023	n/a	n/a	₹32m
Jun 30 2023	n/a	n/a	₹33m
Mar 31 2023	₹4m	n/a	₹32m
Dec 31 2022	n/a	n/a	₹25m
Sep 30 2022	n/a	n/a	₹26m
Jun 30 2022	n/a	n/a	₹20m
Mar 31 2022	₹4m	n/a	₹2m
Dec 31 2021	n/a	n/a	-₹24m
Sep 30 2021	n/a	n/a	-₹35m
Jun 30 2021	n/a	n/a	-₹34m
Mar 31 2021	₹3m	₹3m	-₹26m
Dec 31 2020	n/a	n/a	-₹46m
Sep 30 2020	n/a	n/a	-₹41m
Jun 30 2020	n/a	n/a	-₹49m
Mar 31 2020	₹3m	₹3m	-₹39m
Dec 31 2019	n/a	n/a	-₹7m
Sep 30 2019	n/a	n/a	₹1m
Jun 30 2019	n/a	n/a	₹16m
Mar 31 2019	₹4m	₹4m	₹16m
Dec 31 2018	n/a	n/a	₹16m
Sep 30 2018	n/a	n/a	₹21m
Jun 30 2018	n/a	n/a	₹20m
Mar 31 2018	₹3m	₹3m	₹13m

보상 대 시장: Sunil 의 총 보상 ($USD 50.32K )은 Indian 시장( $USD 38.49K ).

보상과 수익: Sunil 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Sunil Choksi (69 yo)

15.8yrs

테뉴어

₹4,200,000

보상

Mr. Sunil Kumar Choksi serves as the Chief Executive Officer, Chairman and Managing Director at Choksi Laboratories Ltd and has been its Executive Director since September 01, 2008.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sunil Choksi	CEO, MD & Executive Chairman	15.8yrs	₹4.20m	13.25% ₹ 51.7m
Vyangesh Choksi	CFO & Whole-Time Director	14.9yrs	₹3.30m	6.42% ₹ 25.0m
Himika Varma	COO & Whole Time Director	7.3yrs	₹3.30m	0.014% ₹ 56.0k
Stela Choksi	Whole-Time Director	13.3yrs	₹3.00m	3.16% ₹ 12.3m
Raghmendra Singh	Independent Non-Executive Director	1.9yrs	데이터 없음	데이터 없음
Meenaxi Patidar	Independent Non-Executive Director	less than a year	데이터 없음	데이터 없음

10.3yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 이사회: 526546 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.2 년).

Choksi Laboratories 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Choksi Laboratories Limited, Annual General Meeting, Sep 27, 2023

Choksi Laboratories Limited Appoints Prakhar Dubey as Company Secretary and Compliance Officer

Choksi Laboratories Limited Proposes the Resignation of Yash Gupta from the Post of Company Secretary and Compliance Officer

Less than half of directors are independent

Choksi Laboratories Limited Appoints Mr. Raghmendra Singh as an Independent Director

Recent updates

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: ₹1.59 (vs ₹4.61 in FY 2023)

Choksi Laboratories Limited to Report Q4, 2024 Results on May 29, 2024

Now 20% undervalued

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 23%

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 24%

Now 20% undervalued after recent price drop

Third quarter 2024 earnings released: EPS: ₹0.09 (vs ₹0.19 loss in 3Q 2023)

Less than half of directors are independent

Choksi Laboratories Limited to Report Q3, 2024 Results on Feb 03, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.08 in 2Q 2023)

Investor sentiment improves as stock rises 16%

Choksi Laboratories Limited to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: ₹0.51 (vs ₹0.43 in 1Q 2023)

Choksi Laboratories Limited, Annual General Meeting, Sep 27, 2023

Choksi Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023

Investor sentiment improves as stock rises 31%

Choksi Laboratories Limited Appoints Prakhar Dubey as Company Secretary and Compliance Officer

Choksi Laboratories Limited Proposes the Resignation of Yash Gupta from the Post of Company Secretary and Compliance Officer

Investor sentiment improves as stock rises 18%

Full year 2023 earnings released: EPS: ₹4.61 (vs ₹0.30 in FY 2022)

Choksi Laboratories Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: ₹0.19 loss per share (vs ₹0.04 profit in 3Q 2022)

Choksi Laboratories Limited to Report Q3, 2023 Results on Feb 13, 2023

Investor sentiment improves as stock rises 19%

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Choksi Laboratories Limited to Report Q2, 2023 Results on Nov 12, 2022

Investor sentiment improved over the past week

Choksi Laboratories Limited Appoints Mr. Raghmendra Singh as an Independent Director

Choksi Laboratories Limited Proposes Resignation of Directors

Choksi Laboratories Limited to Report Q4, 2022 Results on May 28, 2022

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: ₹0.75 loss per share (vs ₹0.54 loss in 2Q 2021)

Second quarter 2022 earnings released: ₹0.75 loss per share (vs ₹0.54 loss in 2Q 2021)

First quarter 2022 earnings released: ₹2.20 loss per share (vs ₹1.10 loss in 1Q 2021)

Full year 2021 earnings released: ₹3.74 loss per share (vs ₹5.58 loss in FY 2020)

New 90-day low: ₹8.93

Third quarter 2021 earnings released: ₹1.55 loss per share (vs ₹0.75 loss in 3Q 2020)

Choksi Laboratories Limited to Report Q3, 2021 Results on Feb 10, 2021

New 90-day high: ₹11.51

Choksi Laboratories Limited to Report Q4, 2020 Results on Jul 30, 2020

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령